SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (8675)3/17/2001 4:16:44 PM
From: Mark Bong  Read Replies (1) of 9719
 
Rick, pay attention to options expiration.

quote.cboe.com

If you look at a number of biotechs that were hit this week, you will see that options traders absolutely cleaned up. Clearly, trading firms made a major effort to push equity price levels down to enhance put value while taking the calls that they sold out of the money. Taking a quick look at the larger cap biotechs, options look bullish beginning in May, but April could still see some valuation trouble. IMHO. This may coincide with tax related selling.

Vector & rkrw, thanks for the comment on INCY/MLNM all of which make a lot of sense.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext